Icatibant Acetate and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Icatibant Acetate and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: icatibant
Brand name: Firazyr
Synonyms: Icatibant
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Icatibant Acetate-Insulin degludec
- Icatibant Acetate-Insulin Degludec (U-100) Prefilled Pens
- Icatibant Acetate-Insulin Degludec (U-100) Vials
- Icatibant Acetate-Insulin Degludec (U-200) Prefilled Pens
- Icatibant Acetate-Insulin degludec and liraglutide
- Icatibant Acetate-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Icatibant Injection
- Insulin aspart, recombinant Subcutaneous-Icatibant Subcutaneous
- Insulin aspart, recombinant Subcutaneous-ICG for Injection Set
- Insulin aspart, recombinant Subcutaneous-Iclevia
- Insulin aspart, recombinant Subcutaneous-Iclusig
- Insulin aspart, recombinant Subcutaneous-Icosapent